Compare Mitosis (MITO) vs Xertra (STRAX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Mitosis vs Xertra — how do they compare? Mitosis trades at Rp454.01 (market cap Rp82,1M, Rp73,7M 24h volume), while Xertra trades at Rp147.7 (market cap Rp322,67M, Rp8,57M 24h volume). The key difference: Xertra is far larger — about 3.9× Mitosis's market cap, and Mitosis's supply is capped (181,3M / 1B MITO (19%)) while Xertra's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold Mitosis for 20 Days and Xertra for 39 Days on average.
| MITO | STRAX | |
|---|---|---|
Market Cap | Rp82,1M | Rp322,67M |
Volume (24h) | Rp73,7M | Rp8,57M |
Circulating Supply | 181,3M / 1B MITO (19%) | 2,2B STRAX |
Typical Hold Time | 20 Days | 39 Days |
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Mitosis
Mitosis is a cross-chain DeFi protocol that converts liquidity positions into programmable and composable assets. It tackles two significant inefficiencies in decentralized finance: the illiquidity of staked assets and limited access to high-yield opportunities for smaller users.
Read more on MITO →About Xertra
Stratis is a blockchain-as-a-service platform that offers several products and services for enterprises, including launching private sidechains, running full nodes, developing and deploying smart contracts, an initial coin offering platform, and a proof-of-identity application. The company also provides cryptocurrency wallets and blockchain consulting services.
Read more on STRAX →
